Status:
COMPLETED
Prediction of Childhood Epilepsy Outcome in Bangladesh
Lead Sponsor:
Institute of Child Health
Conditions:
Epilepsy
Eligibility:
All Genders
2-16 years
Phase:
NA
Brief Summary
Randomised controlled trial of the use of phenobarbitone and carbamazepine in childhood epilepsy in Bangladesh with particular reference to behavioural side effects.
Eligibility Criteria
Inclusion
- Active epilepsy
- Aged 2-15 years
Exclusion
- Excluded absence
- Myoclonic and malignant epilepsy syndromes
- Major motor and cognitive impairments
- Those currently receiving antiepilepsy drugs.
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT00381537
Last Update
December 25 2006
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital Dhaka (Shishu) Bangladesh.
Sher-e-Bangla Nagar, Dhaka 1207, Bangladesh
2
Institute of Child Health
London, United Kingdom, WC1N 1EH